NCT02853500 Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies Status WITHDRAWN Phase PHASE4
NCT02841800 Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis Status COMPLETED Phase NA
NCT02834780 Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE1
NCT02821754 A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) Status COMPLETED Phase PHASE2
NCT02811666 Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive Cancers Status UNKNOWN Phase NA
NCT02772575 A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE) Status WITHDRAWN Phase N/A
NCT02721056 NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers Status TERMINATED Phase PHASE1/PHASE2
NCT02716012 First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02687113 Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US Fusion Status COMPLETED Phase NA
NCT02662348 T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System Status UNKNOWN Phase PHASE1
NCT02654028 Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection Status COMPLETED Phase NA
NCT02649868 LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors Status TERMINATED Phase NA
NCT02649153 Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection Status COMPLETED Phase PHASE3
NCT02646137 Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma Status UNKNOWN Phase PHASE3
NCT02632188 Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1/PHASE2